You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pb-203

Showing 1 - 25 of 372
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1 Trial ([203Pb]VMT-a-NET, SPECT/CT)

Enrolling by invitation
  • Neuroendocrine Tumor Grade 2
  • Neuroendocrine Tumor Grade 1
  • Iowa City, Iowa
    The University of Iowa
Dec 9, 2022

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,

Recruiting
  • Neuroendocrine Tumors
  • +4 more
  • [212Pb] VMT-α-NET
  • [203Pb] VMT-α-NET SPECT/CT
  • Iowa City, Iowa
    Holden Comprehensive Cancer Center at the University of Iowa
Nov 30, 2023

Melanoma (Skin), Melanoma Stage IV, Melanoma, Uveal Trial in Rochester ([203Pb]VMT01, [68Ga]VMT02)

Recruiting
  • Melanoma (Skin)
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Aug 5, 2022

Melanoma (Skin), Metastatic Melanoma, Melanoma Stage IV Trial in Iowa City, Rochester, Madison ([212Pb]VMT01)

Not yet recruiting
  • Melanoma (Skin)
  • +5 more
  • Iowa City, Iowa
  • +2 more
Dec 8, 2022

Carcinoid Tumor Lung, Neuroendocrine Tumor of the Lung, Carcinoma, Small-Cell Lung Trial in Iowa City (212-Lead Pentixather,

Not yet recruiting
  • Carcinoid Tumor Lung
  • +2 more
  • 212-Lead Pentixather
  • 203-Lead Pentixather SPECT/CT
  • Iowa City, Iowa
    The University of Iowa Theranostics Center
Sep 23, 2022

IgA Nephropathy, Berger Disease Trial in Worldwide (Atacicept, Placebo to match Atacicept)

Active, not recruiting
  • IgA Nephropathy
  • Berger Disease
  • Atacicept
  • Placebo to match Atacicept
  • Tucson, Arizona
  • +75 more
Jul 6, 2022

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

Not yet recruiting
  • Neuroendocrine Tumors
  • +8 more
  • Iowa City, Iowa
  • +1 more
Nov 23, 2022

Transperineal Versus Transrectal Prostate Biopsy

Completed
  • Prostate Cancer
  • prostate biopsy
  • Maastricht, Netherlands
    Maastricht University Medical Center
Sep 5, 2023

ADjuvant chemotherAPy After Curative Intent resecTion of

Recruiting
  • Ampullary Adenocarcinoma
  • Brescia, BS, Italy
    Fondazione Poliambulanza
Oct 3, 2023

MPS-IH (Hurler Syndrome) Trial in Worldwide (Experimental: OTL-203, Active Comparator: Allo-HSCT)

Not yet recruiting
  • MPS-IH (Hurler Syndrome)
  • Experimental: OTL-203
  • Active Comparator: Allo-HSCT
  • Oakland, California
  • +6 more
Nov 27, 2023

Study of Subjects Who Received ICM-203 or Matching Placebo

Not yet recruiting
  • Osteoarthritis, Knee
  • ICM-203
  • Placebo
  • Adelaide, South Australia, Australia
  • +1 more
Feb 21, 2023

Healthy Trial in Busan (EB-203, Placebo)

Recruiting
  • Healthy
  • Busan, Korea, Republic of
    Busan Paik Hospital, Inje University
Sep 11, 2022

Becker Muscular Dystrophy Trial in Atlanta (EDG-5506)

Enrolling by invitation
  • Becker Muscular Dystrophy
  • Atlanta, Georgia
    Rare Disease Research
Sep 27, 2023

Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, NSCLC Trial in United States (LYL797)

Recruiting
  • Triple Negative Breast Cancer
  • +14 more
  • LYL797
  • Scottsdale, Arizona
  • +10 more
Jan 30, 2023

Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple

Recruiting
  • Triple Negative Breast Cancer
    • New Haven, Connecticut
    • +2 more
    Jan 4, 2023

    Infertility Unexplained, Endometriosis Trial in Banha (Laparoscopic Exploration, Estimation of Plasma Expression level of MICRO

    Completed
    • Infertility Unexplained
    • Endometriosis
    • Laparoscopic Exploration
    • Estimation of Plasma Expression level of MICRO RNA 203 & 210
    • Banhā, El- Qalyobia, Egypt
      Banha University
    Jan 10, 2023

    Osteoarthritis, Knee Trial in Woolloongabba, Adelaide, Geelong (ICM-203, Placebo (saline solution))

    Recruiting
    • Osteoarthritis, Knee
    • ICM-203
    • Placebo (saline solution)
    • Woolloongabba, Queensland, Australia
    • +2 more
    Sep 6, 2022

    Obesity Trial in Beijing (PB-718, Placebo)

    Recruiting
    • Obesity
    • Beijing, Beijing, China
      Peking University Third Hospital
    Nov 24, 2023

    Fabry Disease Trial in Worldwide (pegunigalsidase alfa)

    Enrolling by invitation
    • Fabry Disease
    • pegunigalsidase alfa
    • Birmingham, Alabama
    • +28 more
    Feb 14, 2022

    High Risk CLL, Chronic Lymphocytic Leukemia Trial (VenObi+Ven or VenObi+VenZan)

    Not yet recruiting
    • High Risk CLL
    • Chronic Lymphocytic Leukemia
    • VenObi+Ven or VenObi+VenZan
    • (no location specified)
    Jul 26, 2022

    Relapsed or Refractory Hodgkin Lymphoma, Peripheral T Cell Lymphoma Trial (AFM13, AB-101, Cyclophosphamide)

    Not yet recruiting
    • Relapsed or Refractory Hodgkin Lymphoma
    • Peripheral T Cell Lymphoma
    • (no location specified)
    May 30, 2023

    Cervical Cancer, Prostate Cancer Metastatic, Breast Cancer Trial (²¹²Pb-DOTAM-GRPR1)

    Recruiting
    • Cervical Cancer
    • +5 more
    • Chicago, Illinois
    • +3 more
    Jan 24, 2023

    Obesity Trial in Cork (Probiotic capsule (L. reuteri PB-W1™), Placebo sachet, Prebiotic sachet (Prebiotic Blend), Placebo

    Recruiting
    • Obesity
    • Probiotic capsule (L. reuteri PB-W1™), Placebo sachet
    • +3 more
    • Cork, Ireland
      University College Cork
    Jul 5, 2023

    Acute Respiratory Distress Syndrome, Infections Trial (Rhu-pGSN, normal saline)

    Not yet recruiting
    • Acute Respiratory Distress Syndrome
    • Infections
    • (no location specified)
    Jul 16, 2023

    Prostatic Tumors, Castration-Resistant Trial in Brisbane ([212Pb]Pb-ADVC001)

    Not yet recruiting
    • Prostatic Neoplasms
    • Castration-Resistant
    • Brisbane, Queensland, Australia
      Royal Brisbane & Women's Hospital
    Feb 9, 2023